These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
348 related articles for article (PubMed ID: 34445587)
21. Effect of preparation temperature on the characteristics and release profiles of PLGA microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method. Yang YY; Chia HH; Chung TS J Control Release; 2000 Oct; 69(1):81-96. PubMed ID: 11018548 [TBL] [Abstract][Full Text] [Related]
22. Ultrasonic atomization and subsequent polymer desolvation for peptide and protein microencapsulation into biodegradable polyesters. Felder ChB; Blanco-Príeto MJ; Heizmann J; Merkle HP; Gander B J Microencapsul; 2003; 20(5):553-67. PubMed ID: 12909541 [TBL] [Abstract][Full Text] [Related]
23. Injectable, long-acting PLGA formulations: Analyzing PLGA and understanding microparticle formation. Park K; Skidmore S; Hadar J; Garner J; Park H; Otte A; Soh BK; Yoon G; Yu D; Yun Y; Lee BK; Jiang X; Wang Y J Control Release; 2019 Jun; 304():125-134. PubMed ID: 31071374 [TBL] [Abstract][Full Text] [Related]
24. Different ratios of lactide and glycolide in PLGA affect the surface property and protein delivery characteristics of the PLGA microspheres with hydrophobic additives. Chung TW; Tsai YL; Hsieh JH; Tsai WJ J Microencapsul; 2006 Feb; 23(1):15-27. PubMed ID: 16830974 [TBL] [Abstract][Full Text] [Related]
25. Ketotifen-loaded microspheres prepared by spray-drying poly(D,L-lactide) and poly(D,L-lactide-co-glycolide) polymers: characterization and in vivo evaluation. Guerrero S; Muñíz E; Teijón C; Olmo R; Teijón JM; Blanco MD J Pharm Sci; 2008 Aug; 97(8):3153-69. PubMed ID: 18023014 [TBL] [Abstract][Full Text] [Related]
26. Importance of single or blended polymer types for controlled in vitro release and plasma levels of a somatostatin analogue entrapped in PLA/PLGA microspheres. Blanco-Príeto MJ; Campanero MA; Besseghir K; Heimgatner F; Gander B J Control Release; 2004 May; 96(3):437-48. PubMed ID: 15120900 [TBL] [Abstract][Full Text] [Related]
27. Plasma protein adsorption on biodegradable microspheres consisting of poly(D,L-lactide-co-glycolide), poly(L-lactide) or ABA triblock copolymers containing poly(oxyethylene). Influence of production method and polymer composition. Lück M; Pistel KF; Li YX; Blunk T; Müller RH; Kissel T J Control Release; 1998 Nov; 55(2-3):107-20. PubMed ID: 9795026 [TBL] [Abstract][Full Text] [Related]
28. Ultrasound-induced degradation of PLA and PLGA during microsphere processing: influence of formulation variables. Reich G Eur J Pharm Biopharm; 1998 Mar; 45(2):165-71. PubMed ID: 9704913 [TBL] [Abstract][Full Text] [Related]
29. Determinants of release rate of tetanus vaccine from polyester microspheres. Alonso MJ; Cohen S; Park TG; Gupta RK; Siber GR; Langer R Pharm Res; 1993 Jul; 10(7):945-53. PubMed ID: 8378256 [TBL] [Abstract][Full Text] [Related]
30. Recombinant human erythropoietin (rhEPO) loaded poly(lactide-co-glycolide) microspheres: influence of the encapsulation technique and polymer purity on microsphere characteristics. Bittner B; Morlock M; Koll H; Winter G; Kissel T Eur J Pharm Biopharm; 1998 May; 45(3):295-305. PubMed ID: 9653634 [TBL] [Abstract][Full Text] [Related]
31. Preparation and evaluation of injectable microsphere formulation for longer sustained release of donepezil. Ji YB; Lee S; Ju HJ; Kim HE; Noh JH; Choi S; Park K; Lee HB; Kim MS J Control Release; 2023 Apr; 356():43-58. PubMed ID: 36841288 [TBL] [Abstract][Full Text] [Related]
32. Feeding liquid, non-ionic surfactant and cyclodextrin affect the properties of insulin-loaded poly(lactide-co-glycolide) microspheres prepared by spray-drying. Quaglia F; De Rosa G; Granata E; Ungaro F; Fattal E; Immacolata La Rotonda M J Control Release; 2003 Jan; 86(2-3):267-78. PubMed ID: 12526823 [TBL] [Abstract][Full Text] [Related]
33. Controlled delivery of drugs from a novel injectable in situ formed biodegradable PLGA microsphere system. Jain RA; Rhodes CT; Railkar AM; Malick AW; Shah NH J Microencapsul; 2000; 17(3):343-62. PubMed ID: 10819422 [TBL] [Abstract][Full Text] [Related]
34. Comparison of various injectable protein-loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices: in-situ-formed implant versus in-situ-formed microspheres versus isolated microspheres. Jain RA; Rhodes CT; Railkar AM; Malick AW; Shah NH Pharm Dev Technol; 2000; 5(2):201-7. PubMed ID: 10810750 [TBL] [Abstract][Full Text] [Related]
35. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Jain RA Biomaterials; 2000 Dec; 21(23):2475-90. PubMed ID: 11055295 [TBL] [Abstract][Full Text] [Related]
36. Encapsulation of protamine sulphate compacted DNA in polylactide and polylactide-co-glycolide microparticles. Dunne M; Bibby DC; Jones JC; Cudmore S J Control Release; 2003 Sep; 92(1-2):209-19. PubMed ID: 14499198 [TBL] [Abstract][Full Text] [Related]
37. Biodegradable microspheres as controlled-release tetanus toxoid delivery systems. Alonso MJ; Gupta RK; Min C; Siber GR; Langer R Vaccine; 1994 Mar; 12(4):299-306. PubMed ID: 8178550 [TBL] [Abstract][Full Text] [Related]
38. Recent Advance in Polymer Based Microspheric Systems for Controlled Protein and Peptide Delivery. Yang Y; Chen Q; Lin J; Cai Z; Liao G; Wang K; Bai L; Zhao P; Yu Z Curr Med Chem; 2019; 26(13):2285-2296. PubMed ID: 30963961 [TBL] [Abstract][Full Text] [Related]
39. The effect of different grades of PLGA on characteristics of microspheres encapsulated with cyclosporine A. Malaekeh-Nikouei B; Sajadi Tabassi SA; Jaafari MR Curr Drug Deliv; 2006 Oct; 3(4):343-9. PubMed ID: 17076635 [TBL] [Abstract][Full Text] [Related]
40. Synthesis of uniform poly(d,l-lactide) and poly(d,l-lactide-co-glycolide) microspheres using a microfluidic chip for comparison. Yang CH; Huang KS; Grumezescu AM; Wang CY; Tzeng SC; Chen SY; Lin YH; Lin YS Electrophoresis; 2014 Feb; 35(2-3):316-22. PubMed ID: 23857679 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]